Division of Vascular Surgery, Eastern Virginia Medical School, Norfolk, Va.
Division of Vascular Surgery, Eastern Virginia Medical School, Norfolk, Va.
J Vasc Surg. 2020 Apr;71(4):1088-1096. doi: 10.1016/j.jvs.2019.07.084. Epub 2020 Feb 13.
Intramural hematoma (IMH) is on the spectrum of acute aortic syndrome, but optimal management is poorly understood. The aim of this study was to evaluate outcomes of patients with type B IMH (TBIMH) after best medical therapy (BMT) and to assess for risk factors associated with failure of BMT.
This is a single-institution retrospective chart review of all patients with TBIMH between January 2008 and December 2017. Failure of BMT was defined as any of the following end points: aortic rupture, aorta-related death, aortic enlargement to at least 55 mm or growth of >10 mm within 12 months, or need for surgical aortic intervention for failed BMT.
We identified 92 patients, of whom 25 received emergent thoracic endovascular aortic repair; 67 patients were initially managed with BMT, and of these, 32 underwent thoracic endovascular aortic repair within 14 days for early BMT failure. Two additional patients had early BMT failure; one died of aortic rupture due to retrograde type A dissection, and one patient was advised to undergo repair but did not comply and was lost to follow-up. Fourteen patients (20.9%) received endovascular therapy for late failure of BMT after the initial hospitalization. Medical management was successful in 19 patients (28.4%), although 5 patients had aortic enlargement but below the threshold for elective repair (maximal aortic diameter of 55 mm). On univariate analysis, presenting IMH thickness and growth of IMH thickness were risk factors for BMT failure. On multivariate analysis, presenting IMH thickness was the sole predictive risk factor for medical therapy failure (odds ratio, 1.083; 95% confidence interval, 1.021-1.149; P = .008), with an odds ratio of 6.810 (95% confidence interval, 1.921-24.146; P = .002) with a presenting IMH thickness of ≥8.0 mm, which was the calculated IMH thickness cutoff value with highest sensitivity and specificity to predict failure of BMT (area under the receiver operating characteristic curve = 0.795; P = .001; J = 0.62).
BMT for TBIMH is associated with a high failure rate and need for interventions. IMH thickness on admission is the most reliable factor to predict failure of BMT.
壁内血肿(IMH)是急性主动脉综合征的一种,但对其最佳治疗方法了解甚少。本研究旨在评估接受最佳药物治疗(BMT)后的 B 型壁内血肿(TBIMH)患者的结局,并评估与 BMT 失败相关的危险因素。
这是一项对 2008 年 1 月至 2017 年 12 月期间所有 TBIMH 患者的单中心回顾性图表分析。BMT 失败的定义为以下任何终点:主动脉破裂、与主动脉相关的死亡、12 个月内主动脉扩张至至少 55mm 或扩张>10mm、或因 BMT 失败而行外科主动脉介入治疗。
共纳入 92 例患者,其中 25 例行急诊胸主动脉腔内修复术;67 例患者最初接受 BMT 治疗,其中 32 例在 14 天内行胸主动脉腔内修复术,治疗早期 BMT 失败。另外 2 例患者早期 BMT 失败;1 例死于因逆行型 A 型夹层导致的主动脉破裂,1 例患者建议行修复术,但未遵医嘱,且失访。14 例(20.9%)患者在最初住院后因 BMT 晚期失败而行血管内治疗。19 例(28.4%)患者接受药物治疗成功,尽管 5 例患者主动脉扩张,但未达到择期修复的阈值(最大主动脉直径 55mm)。单因素分析显示,初始 IMH 厚度和 IMH 厚度增加是 BMT 失败的危险因素。多因素分析显示,初始 IMH 厚度是唯一与药物治疗失败相关的预测危险因素(比值比,1.083;95%置信区间,1.021-1.149;P=0.008),初始 IMH 厚度≥8.0mm 的比值比为 6.810(95%置信区间,1.921-24.146;P=0.002),该值为预测 BMT 失败的最佳 IMH 厚度截断值,具有最高的灵敏度和特异性(受试者工作特征曲线下面积为 0.795;P=0.001;J=0.62)。
TBIMH 的 BMT 治疗后复发率和需要干预的概率均较高。入院时的 IMH 厚度是预测 BMT 失败的最可靠因素。